Quick Answer: Can I Survive Her2 Positive Breast Cancer?

Does her2 negative require chemo?

Most patients with metastatic breast cancer have HER2-negative breast cancer.

If HER2-negative breast cancer is also hormone receptor positive, the most common treatment is hormonal therapy, but chemotherapy or targeted therapy may also be given..

Is it better to be ER PR positive or negative?

Women with hormone receptor-positive cancers tend to have a better outlook in the short-term, but these cancers can sometimes come back many years after treatment. Hormone receptor-negative (or hormone-negative) breast cancers have neither estrogen nor progesterone receptors.

What is the survival rate of her2 negative breast cancer?

The 5-year survival rate for stage 1 triple-negative breast cancer is 85%.

What is the most aggressive type of breast cancer?

The most aggressive breast cancers include: Triple-negative breast cancer: This type of breast cancer tests negative for the hormones estrogen and progesterone, and the protein HER2. Inflammatory breast cancer: This rare form of cancer is named because it causes breast swelling and redness.

Which type of breast cancer has the best prognosis?

Mucinous Ductal Carcinoma – This occurs when cancer cells within the breast produce mucous, which also contains breast cancer cells. The cells and mucous combine to form a tumor. Pure mucinous ductal carcinoma carries a better prognosis than more common types of IDCs.

Is her2 positive good?

About 25% of breast cancers are HER2-positive. HER2-positive cancers are a mix of good and bad news. The bad news is the tumors tend to grow more aggressively than those without the HER2 receptor. The good news is that like ER/PR-positive cancers, medicines can switch the HER2 growth receptor off.

What is the survival rate of her2 positive breast cancer?

For perspective, most patients with stage 1 HER2-positive breast cancer, receive targeted therapy drugs like trastuzumab (brand name Herceptin) and pertuzumab (brand name Perjeta) and chemotherapy. This approach results in a 7-year disease-free survival rate of about 93%.

Is it better to be her2 positive or negative?

While overall the prognosis of HER2-positive tumors tends to be somewhat poorer than for those that are estrogen receptor-positive but HER2-negative, the widespread adoption of HER2 therapies is making a difference in survival rates, as well as reduced risk for recurrence.

Can you live 20 years after breast cancer?

Since the hazard rate associated with inflammatory breast cancer shows a sharp peak within the first 2 years and a rapid reduction in risk in subsequent years, it is highly likely that the great majority of patients alive 20 years after diagnosis are cured.

Is chemo necessary for her2 positive?

Many studies have shown that these treatments dramatically improve survival for women with HER2-positive breast cancer. Trastuzumab and chemotherapy are even recommended for women with very small, HER2-positive breast cancers. Tumors as small as 0.5 cm often warrant such treatment.

What causes her2 positive?

In about 25 percent of breast cancers, the cancer cells have an excess of the HER2 protein. This is caused by a mutation in the HER2 (human epidermal growth factor receptor 2) gene. When the HER2 gene mutates, it causes cells in the breast to grow and divide at an uncontrolled rate, leading to tumor growth.

Can her2 negative Be Cured?

When you have HER2-negative advanced (metastatic) breast cancer, treatment usually focuses on managing your disease, not curing the cancer. The goal is to help you live longer and have a better quality of life. This type of cancer is most often treated with systemic therapy.

What foods should her2 positive avoid?

Foods to avoid if you have HER2-positive breast cancerSugary foods include refined or simple carbohydrates or starches. … Eating too many saturated fats can raise your cholesterol levels. … A 2014 study found that a high-fat diet is strongly linked to HER2-positive breast cancer.

How fast does her2 positive grow?

Daily growth rate based on type was: 1.003 percent per day increase for triple negative tumors. 0.859 percent per day for HER2 positive/estrogen receptor negative tumors. 0.208 percent per day increase for estrogen receptor-positive tumors2